Literature DB >> 3070266

Properties of high and low density subpopulations of group B streptococci: enhanced virulence of the low density variant.

S Håkansson1, A M Bergholm, S E Holm, B Wagner, M Wagner.   

Abstract

From the group B streptococcus (GBS) reference strain 090 la Colindale two subpopulations, which differed markedly regarding their capacities for biosynthesis of type-specific polysaccharide, were obtained by separation on a hypotonic Percoll density gradient. In the original strain and the high and low density variants, there was a negative correlation between buoyant density and bio-synthesis of type-specific polysaccharide as determined by ultrastructure and quantitative assays. The invasiveness of these variants was investigated by infecting rabbits via subcutaneously implanted tissue cages. In the animals infected with highly encapsulated bacteria, heavy bacteremia was detected 8 h post-infection, whereas in the animals which received high density bacteria with small amount of capsule, heavy bacteremia was not detected until after five days. All isolates recovered from the blood or organs of these rabbits were of the capsule rich phenotype, indicating a phenotypic shift in the subpopulation of high density bacteria. An apparently similar phenotypic shift was noted in an isolate from a baby with early onset septicemia. There was a dominance of low density bacteria in the isolate obtained from the baby as compared with the colonizing population of bacteria isolated from the cervix of the mother. From these type III isolates, subpopulations with different density maxima were obtained. A reversed shifting towards dominance of less encapsulated, high density bacteria was observed during in vitro passage of these subpopulations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3070266     DOI: 10.1016/0882-4010(88)90035-6

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  11 in total

1.  Inhibition enzyme-linked immunosorbent assay for serotyping of group B streptococcal isolates.

Authors:  G Arakere; A E Flores; P Ferrieri; C E Frasch
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

2.  Streptococcus iniae phosphoglucomutase is a virulence factor and a target for vaccine development.

Authors:  John T Buchanan; Jason A Stannard; Xavier Lauth; Vaughn E Ostland; Henry C Powell; Mark E Westerman; Victor Nizet
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Streptococcus iniae virulence is associated with a distinct genetic profile.

Authors:  J D Fuller; D J Bast; V Nizet; D E Low; J C de Azavedo
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Surfactant improves lung function and mitigates bacterial growth in immature ventilated rabbits with experimentally induced neonatal group B streptococcal pneumonia.

Authors:  E Herting; B Sun; C Jarstrand; T Curstedt; B Robertson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-01       Impact factor: 5.747

5.  Activity of polymorphonuclear leukocytes in the presence of sulfide.

Authors:  R Claesson; M Granlund-Edstedt; S Persson; J Carlsson
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

6.  Endocarditis caused by a group B Streptococcus strain, type III, in a nonencapsulated phase.

Authors:  M Sellin; M Linderholm; M Norgren; S Håkansson
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

7.  Genetic and biochemical modulation of sialic acid O-acetylation on group B Streptococcus: phenotypic and functional impact.

Authors:  Shannon Weiman; Samira Dahesh; Aaron F Carlin; Ajit Varki; Victor Nizet; Amanda L Lewis
Journal:  Glycobiology       Date:  2009-07-30       Impact factor: 4.313

8.  Cell growth rate regulates expression of group B Streptococcus type III capsular polysaccharide.

Authors:  L C Paoletti; R A Ross; K D Johnson
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

9.  Streptococcus suis Serotype 2 Capsule In Vivo.

Authors:  Jean-Philippe Auger; Nattakan Meekhanon; Masatoshi Okura; Makoto Osaki; Marcelo Gottschalk; Tsutomu Sekizaki; Daisuke Takamatsu
Journal:  Emerg Infect Dis       Date:  2016-10       Impact factor: 6.883

10.  Pharmacodynamics, population dynamics, and the evolution of persistence in Staphylococcus aureus.

Authors:  Paul J T Johnson; Bruce R Levin
Journal:  PLoS Genet       Date:  2013-01-03       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.